# Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

> **NCT01624064** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ministry of Health, Sri Lanka** · enrollment: 200 (estimated)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Enalapril
- **DRUG:** Calcium Supplement

## Key facts

- **NCT ID:** NCT01624064
- **Lead sponsor:** Ministry of Health, Sri Lanka
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** 2013-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01624064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01624064, "Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01624064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*